Retrieve available abstracts of 266 articles: HTML format
Single Articles
May 2025
AFIFAH NN, Intania R, Wijaya I, Obinata H, et al The interplay between TB and lung cancer: risk, prognosis and treatment dynamics.
Int J Tuberc Lung Dis. 2025;29:243-252. PubMedAbstract available
DONKENG DONFACK VF, Ninkeh Nono V, Napa Tchuedji YLG, Ongboulal SM, et al Performances of loop-mediated isothermal amplification for TB diagnosis in
children.
Int J Tuberc Lung Dis. 2025;29:259-264. PubMedAbstract available
CHANI K, Athallah MA, Colquhoun S, Tsheten T, et al Proportions of Xpert MTB/RIF Ultra 'trace' results vary widely among different
populations with presumptive TB.
Int J Tuberc Lung Dis. 2025;29:271-277. PubMedAbstract available
MUSAAZI J, Sekaggya-Wiltshire C, Zawedde-Muyanja S, Kalema N, et al TB incidence following accelerated TB preventive treatment scale-up campaigns in
Uganda.
Int J Tuberc Lung Dis. 2025;29:253-258. PubMedAbstract available
TABACKMAN A, Gupte AN, Thangakunam B, Babu SP, et al Impact of premorbid nutritional status on TB severity.
Int J Tuberc Lung Dis. 2025;29:265-270. PubMedAbstract available
MIN J, Park JE, Kim SY, Kim YY, et al Disability is a risk factor for 1-year mortality after TB diagnosis.
Int J Tuberc Lung Dis. 2025;29:207-213. PubMedAbstract available
CHE B, Peng Y, Zheng X, Chen B, et al Attrition in the treatment cascade among elderly patients with
multidrug-resistant TB.
Int J Tuberc Lung Dis. 2025;29:218-226. PubMedAbstract available
SCHIUMA M, Colaneri M, Cattaneo D, Fusi M, et al Rifampicin drug monitoring in TB patients: new evidence for increased dosage?
Int J Tuberc Lung Dis. 2025;29:202-206. PubMedAbstract available
MCNALLY G, Solomon D, Brown M, Capocci S, et al A diagnostic certainty score to support improvements in culture confirmation of
TB.
Int J Tuberc Lung Dis. 2025;29:227-230. PubMedAbstract available
March 2025
CAO J, Shao G, Zhong H, Davies Forsman L, et al Population pharmacokinetics and dose evaluation for second-line TB drugs in
patients with diabetes.
Int J Tuberc Lung Dis. 2025;29:164-170. PubMedAbstract available
MULEBEKE R, Chemutai C, Mubangizi I, Balina M, et al Effect of community awareness, screening, diagnosis, and treatment campaigns on
TB care in Uganda.
Int J Tuberc Lung Dis. 2025;29:178-183. PubMedAbstract available
ZAVALA S, Kiritsy MC, Cox GM, Ahmed A, et al Geographic information systems analysis to focus TB screening among people born
in endemic countries.
Int J Tuberc Lung Dis. 2025;29:159-163. PubMedAbstract available
NASIRI MJ, Khoshdel N, Venketaraman V Glutathione and N-acetylcysteine in TB management.
Int J Tuberc Lung Dis. 2025;29:171-177. PubMedAbstract available
NABITY SA, Moffitt AD, Mponda K, Melgar M, et al Urine metabolite-determined isoniazid adherence under programmatic conditions in
people living with HIV.
Int J Tuberc Lung Dis. 2025;29:97-102. PubMedAbstract available
TRAN HT, Nguyen CT, Nguyen HT, Godin I, et al Validation of a questionnaire to screen chronic obstructive respiratory diseases.
Int J Tuberc Lung Dis. 2025;29:113-118. PubMedAbstract available
PONTICIELLO MN, Nanziri LM, Hennein R, Ochom E, et al Adaptation and validation of perceived HIV and TB stigma scales among persons
with TB.
Int J Tuberc Lung Dis. 2025;29:127-134. PubMedAbstract available
TRAM KH, Ong'ang'o J, Kiplimo R, Hawn TR, et al Mobility patterns, activity locations, and TB in Nairobi, Kenya.
Int J Tuberc Lung Dis. 2025;29:103-112. PubMedAbstract available
PRIKHODCHENKO O, Arbuzova Y, Serikbayeva K, Zhakhina G, et al Epidemiology, detection, diagnosis and treatment of TB in children in Kazakhstan.
Int J Tuberc Lung Dis. 2025;29:135-140. PubMedAbstract available
February 2025
BOUZOUITA I, Cabibbe AM, Ghariani A, Smaoui S, et al First report of multidrug-resistant M. tuberculosis Beijing strain isolated from
the indigenous population in Tunisia.
Int J Tuberc Lung Dis. 2025;29:92-94. PubMed
LEGRAND KE, Allel K, Khan P, Hayes RJ, et al Contamination effects in cluster randomised trials of TB interventions.
Int J Tuberc Lung Dis. 2025;29:47-53. PubMedAbstract available
MWANZA W, Lutinala M, Mundia K, Klinkenberg E, et al Stool-based Xpert testing for diagnosis of TB in children and critically ill
adults.
Int J Tuberc Lung Dis. 2025;29:75-79. PubMedAbstract available
NGUENHA D, Ndebele F, Saavedra B, Mambuque E, et al BMI as a predictor of progression from TB infection to active TB in PLHIV.
Int J Tuberc Lung Dis. 2025;29:54-59. PubMedAbstract available
TCHAKOUNTE YOUNGUI B, Tchounga BK, Atwine D, Vasiliu A, et al Safety of 3-month rifampicin-isoniazid TPT in child household contacts in a
community-based intervention.
Int J Tuberc Lung Dis. 2025;29:67-74. PubMedAbstract available
ISLAM MN, Khan MK, Hassan J, Nahar MS, et al Reversible zoonotic transmission of TB from humans to dairy cattle.
Int J Tuberc Lung Dis. 2025;29:80-87. PubMedAbstract available
January 2025
AYALEW S, Wegayehu T, Wondale B, Alemayehu DH, et al Multigene Mycobacterium tuberculosis cell-free DNA assay.
Int J Tuberc Lung Dis. 2025;29:13-19. PubMedAbstract available
MUZANYI G, Ntale M, Salata R, Joloba M, et al Hair isoniazid levels predict TB sputum culture conversion.
Int J Tuberc Lung Dis. 2025;29:1-6. PubMedAbstract available
PRATHIKSHA G, Newtonraj A, Thiruvengadam K, Frederick A, et al TB prevalence is higher among smokers.
Int J Tuberc Lung Dis. 2025;29:29-34. PubMedAbstract available
December 2024
AFAQ S A comprehensive person-centred TB care model, from malnutrition to mental health.
Int J Tuberc Lung Dis. 2024;28:561-563. PubMedAbstract available
SRIVASTAVA S, Gumbo T Examining effective monotherapy hypothesis for TB therapy failure and resistance
emergence.
Int J Tuberc Lung Dis. 2024;28:572-577. PubMedAbstract available
ALATISE MA, Narasimhan P, Gbadamosi MD, Chughtai AA, et al Accessibility and TB patient satisfaction in Nigeria.
Int J Tuberc Lung Dis. 2024;28:585-591. PubMedAbstract available
ROSS J, Cummings MJ, Bakamutumaho B, Tokarz R, et al Xpert MTB/RIF Ultra enables sensitive detection of Mycobacterium tuberculosis in
blood.
Int J Tuberc Lung Dis. 2024;28:594-596. PubMed
November 2024
ENGEL N, Apolosi I, Bhargava A, Bhan A, et al Building social equity and person-centred innovation into the end TB response.
Int J Tuberc Lung Dis. 2024;28:517-520. PubMedAbstract available
SHAPIRO AN, Scott L, Moultrie H, Jacobson KR, et al Risk factors for and timing of presumptive recurrent TB.
Int J Tuberc Lung Dis. 2024;28:527-533. PubMedAbstract available
LIN CM, Chen YL, Cheng YF, Cheng CY, et al Clinical characteristics and decortication outcomes of bacterial, tuberculous and
fungal pleural infection.
Int J Tuberc Lung Dis. 2024;28:541-546. PubMedAbstract available
CHAPMAN HEDGES KN, Scott N, Belknap R, Goldberg SV, et al Reasons for acceptance or nonparticipation in iAdhere: a trial of latent TB
infection treatment.
Int J Tuberc Lung Dis. 2024;28:521-526. PubMedAbstract available
PALMER M, van der Zalm MM, Schaaf HS, Goussard P, et al Approaches and processes for paediatric chest X-ray classification used in the
SHINE TB treatment-shortening trial.
Int J Tuberc Lung Dis. 2024;28:547-553. PubMedAbstract available
October 2024
MALDARI A, Brigham M, Emeto TI, Adegboye O, et al The impact of the COVID-19 pandemic on TB in a low TB burden setting.
Int J Tuberc Lung Dis. 2024;28:510-512. PubMed
VANLEEUW L, Sanchez M, Forse R, Zembe-Mkabile W, et al Making social protection a reality for people with TB: a perspective on new
global guidance.
Int J Tuberc Lung Dis. 2024;28:473-475. PubMedAbstract available
RICCARDI N, Monari C, Antonello RM, Saderi L, et al TB outpatient care in a high-income, low-incidence country.
Int J Tuberc Lung Dis. 2024;28:513-515. PubMed
LARSSON L, Corbett C, Kalmambetova G, Utpatel C, et al Whole-genome sequencing drug susceptibility testing is associated with positive
MDR-TB treatment response.
Int J Tuberc Lung Dis. 2024;28:494-499. PubMedAbstract available
KODAMA T, Chikamatsu K, Kamada K, Mizuno K, et al Evaluation of testing face-mask filter samples with LAMP shows high rates of
detection in pulmonary TB.
Int J Tuberc Lung Dis. 2024;28:476-481. PubMedAbstract available
COLOMB S, Tricot M, Baccino E, Lesage FX, et al Occupational transmission of TB infection during autopsy.
Int J Tuberc Lung Dis. 2024;28:508-509. PubMed
MARTINS MF, Dauphinais MR, Tabackman A, Narasimhan PB, et al Clearing the air: microcosting the carbon impact of drug-susceptible pulmonary TB
treatment.
Int J Tuberc Lung Dis. 2024;28:488-493. PubMedAbstract available
SMIRNOVA N, Bryan CS, Salindri AD, Avaliani T, et al Cavitary lung lesions and quality of life after TB.
Int J Tuberc Lung Dis. 2024;28:505-507. PubMed
September 2024
CEVIK M, Sturdy A, Maraolo AE, Dekkers BGJ, et al A systematic review on the effect of diabetes mellitus on the pharmacokinetics of
TB drugs.
Int J Tuberc Lung Dis. 2024;28:454-460. PubMedAbstract available
MARAIS BJ, Buck WC, Schaaf HS The hidden burden of miliary TB in children and adolescents.
Int J Tuberc Lung Dis. 2024;28:407-409. PubMed
DECKER SR, Marchesan LQ, Silva DW, Deutschendorf C, et al A cohort study exploring variables associated with mortality in critically ill TB
patients.
Int J Tuberc Lung Dis. 2024;28:461-463. PubMed
BUONSENSO D, Mariani F, Morello R, Song R, et al Miliary TB in children and adolescents: a scoping review.
Int J Tuberc Lung Dis. 2024;28:412-418. PubMedAbstract available
NGUYEN LN, Phan PT, Jaramillo E, Dinh A, et al Respiratory impairment after completion of TB treatment: a neglected but vitally
important issue.
Int J Tuberc Lung Dis. 2024;28:410-411. PubMed
AGUIAR A, Abreu M, Gaio R, Duarte R, et al Barriers to TB detection in Portuguese prisons.
Int J Tuberc Lung Dis. 2024;28:464-466. PubMed
BIEWER A, Tintaya K, Roman B, Hurwitz S, et al Diagnostic accuracy of an exhaled breath test for TB in hospitalized patients
with cough or risk.
Int J Tuberc Lung Dis. 2024;28:446-453. PubMedAbstract available
ZAWEDDE J, Abelman R, Musisi E, Nyabigambo A, et al Lung function and health-related quality of life among adult patients following
pulmonary TB treatment.
Int J Tuberc Lung Dis. 2024;28:419-426. PubMedAbstract available
ARMSTRONG-HOUGH M, Shelby T, Ggita J, Nangendo J, et al An adapted scale to measure perceived TB and HIV stigma during household contact
investigation.
Int J Tuberc Lung Dis. 2024;28:433-438. PubMedAbstract available
TAKEDA K, Nagai H, Kawashima M, Kosai I, et al Cold temperatures during sample transportation may cause false-negative
interferon-gamma release assays used to diagnose TB infection.
Int J Tuberc Lung Dis. 2024;28:467-469. PubMed
August 2024
HOOLE AS, Ilyas A, Munawar S, Cant M, et al Post-TB bronchiectasis: clinical characteristics and microbiology.
Int J Tuberc Lung Dis. 2024;28:405-406. PubMed
JASWAL MR, Farooq S, Hussain H, Shah J, et al TB disease yield from household contact screening of TB index patients in
Pakistan.
Int J Tuberc Lung Dis. 2024;28:374-380. PubMedAbstract available
KLAOS K, Agejeva A, Hurt K, Kummik T, et al Prospective evaluation of thin-layer agar colour test in routine diagnosis of
multidrug-resistant TB.
Int J Tuberc Lung Dis. 2024;28:387-394. PubMedAbstract available
DAHL VN, Butova T, Kuzhko M, Sapelnik N, et al HIV remains a deadly companion to drug-resistant TB in Ukraine.
Int J Tuberc Lung Dis. 2024;28:400-402. PubMed
DENHOLM JT, Coussens A, Houben RMGJ, Horton KC, et al The International Consensus for Early TB framework (ICE-TB): Implications from a
low-incidence setting.
Int J Tuberc Lung Dis. 2024;28:381-386. PubMedAbstract available
SIERRA CJ, Huang Y, Cotton SA, Hughes TD, et al Clinical outcomes in comorbid COVID-19 and TB cases.
Int J Tuberc Lung Dis. 2024;28:397-399. PubMed
July 2024
DYTKO O, Park M, Nicholas R, Akshikar R, et al Digital surveillance of ocular toxicity during TB treatment.
Int J Tuberc Lung Dis. 2024;28:360-361. PubMed
HAPPAERTS M, Lorent N, Andre E Exploring the use of exhaled breath as a diagnostic tool for pulmonary TB.
Int J Tuberc Lung Dis. 2024;28:317-321. PubMedAbstract available
LO HY, Huang YC, Chan PC, Lee CC, et al TB notifications among citizens and non-citizens in Taiwan.
Int J Tuberc Lung Dis. 2024;28:328-334. PubMedAbstract available
SEMAKULA L, Kakai I, Zawedde-Muyanja S, Nerima P, et al Private pharmacy and community health worker engagement in the provision of TB
services.
Int J Tuberc Lung Dis. 2024;28:343-347. PubMedAbstract available
GODEFROY N, Monsel G, Jaureguiberry S, Henry B, et al Lessons learned from treating drug-resistant TB and how to apply these to
drug-susceptible TB.
Int J Tuberc Lung Dis. 2024;28:357-359. PubMed
SAVINKINA A, Muyindike W, Hahn JA, Emenyonu NI, et al Strategies for isoniazid preventive therapy in HIV-positive patients who consume
alcohol.
Int J Tuberc Lung Dis. 2024;28:335-342. PubMedAbstract available
PRATHIKSHA G, Selvaraju S, Thiruvengadam K, Frederick A, et al Programmatic implications of a sub-national TB prevalence survey in India.
Int J Tuberc Lung Dis. 2024;28:348-353. PubMedAbstract available
June 2024
MIN J, Kim SY, Park JE, Park JH, et al Did public-private partnerships reduce TB incidence in Korea?
Int J Tuberc Lung Dis. 2024;28:306-308. PubMed
CHIANG SS, Jenkins HE Pediatric TB treatment outcomes: targets for improvement.
Int J Tuberc Lung Dis. 2024;28:263-265. PubMed
DIAS JV, Varandas L, Goncalves L, Kagina B, et al Outcomes of childhood TB in countries with a universal BCG vaccination policy.
Int J Tuberc Lung Dis. 2024;28:273-277. PubMedAbstract available
KIWANUKA N, Quach T, Kakaire R, Zalwango S, et al Incidence of tuberculous infection in a TB-endemic city.
Int J Tuberc Lung Dis. 2024;28:266-272. PubMedAbstract available
PHELAN JE, Utpatel C, Ismail N, Cortes T, et al Careful classification of potential bedaquiline resistance mutations is critical
when analysing their clinical impact.
Int J Tuberc Lung Dis. 2024;28:312-313. PubMed
CARVALHO MM, Barbosa P, Ramos P, Vieira M, et al Limitations of using tuberculin skin test to screen for TB in patients with
psoriasis.
Int J Tuberc Lung Dis. 2024;28:304-305. PubMed
RAMOS-RINCON JM, Montoya B, Simpson G, Burgos M, et al An epidemiological analysis of TB trends in native and migrant populations, New
Mexico, 1993-2021.
Int J Tuberc Lung Dis. 2024;28:278-286. PubMedAbstract available
SHEARER K, Variava E, Kekana B, Abraham P, et al TB diagnoses and mortality in hospitalized people living with HIV in South
Africa.
Int J Tuberc Lung Dis. 2024;28:301-303. PubMed
WORDUI S, Masu A, Golden L, Chaya S, et al Aetiology of pleural effusions in children living in a high TB endemic setting.
Int J Tuberc Lung Dis. 2024;28:295-300. PubMedAbstract available
BONGOMIN F, Denning DW Chronic pulmonary aspergillosis: a neglected post-TB lung disease.
Int J Tuberc Lung Dis. 2024;28:314-315. PubMed
May 2024
PATEL MA, Durovni B, Salazar-Austin N, Cavalcante SC, et al TB prevalence among pregnant women with HIV in Rio de Janeiro, Brazil.
Int J Tuberc Lung Dis. 2024;28:259-261. PubMed
ALLAN-BLITZ LT, Yarbrough C, Ndayizigiye M, Wade C, et al Point-of-care ultrasound for diagnosing extrapulmonary TB.
Int J Tuberc Lung Dis. 2024;28:217-224. PubMedAbstract available
RAUTMAN LH, Kammerer JS, Silk BJ, Marconi VC, et al Characteristics of TB cases without documented sputum culture in the United
States, 2011-2021.
Int J Tuberc Lung Dis. 2024;28:231-236. PubMedAbstract available
MANGAN JM, Hedges KNC, Salerno MM, Tatum K, et al Facilitators and barriers to adolescent participation in a TB clinical trial.
Int J Tuberc Lung Dis. 2024;28:243-248. PubMedAbstract available
WADEMAN DT, Saule Z, Marthinus A, Viljoen L, et al Acceptability of clofazimine capsules in children and adolescents with
rifampicin-resistant TB.
Int J Tuberc Lung Dis. 2024;28:256-258. PubMed
DIAZ YDG, Palma D, Vargas-Leguas H, Rodrigo T, et al Factors associated with referrals for directly observed treatment and
unsuccessful treatment.
Int J Tuberc Lung Dis. 2024;28:237-242. PubMedAbstract available
MARQUES MS, Silva T, Gomes A, Pereira C, et al Factors associated with patient delay in the diagnosis of TB - a study of
health-seeking behaviour.
Int J Tuberc Lung Dis. 2024;28:249-252. PubMed
April 2024
PARREIRA PL, Fonseca AU, Soares F, Conte MB, et al Chest X-ray evaluation using machine learning to support the early diagnosis of
pulmonary TB.
Int J Tuberc Lung Dis. 2024;28:171-175. PubMedAbstract available
DOGO FM, Ate S, Agossou K, Menon S, et al Decentralising DOT for drug-susceptible TB from the health facilities to the
community level in Togo.
Int J Tuberc Lung Dis. 2024;28:195-201. PubMedAbstract available
ILAIWY G, Heysell SK, Lukumay S, Agustino D, et al Cash transfers to enhance completion of TB screening among household contacts in
rural Tanzania.
Int J Tuberc Lung Dis. 2024;28:176-182. PubMedAbstract available
MARKS SM, Winston CA Estimated treatment costs for multidrug-resistant TB in the United States.
Int J Tuberc Lung Dis. 2024;28:214-215. PubMed
KAWATSU L, Uchimura K, Schwalb A, Houben R, et al New perspectives on the secular trend in pulmonary TB in post-war Japan
(1953-1980).
Int J Tuberc Lung Dis. 2024;28:207-209. PubMed
SHAIKH A, Sriraman K, Vaswani S, Shah I, et al SMaRT-PCR: sampling using masks and RT-PCR, a non-invasive diagnostic tool for
paediatric pulmonary TB.
Int J Tuberc Lung Dis. 2024;28:189-194. PubMedAbstract available
March 2024
OTA M, Hirao S, Uchimura K Lower TB notification rates in later life in the same birth cohort, Japan,
1950-2020.
Int J Tuberc Lung Dis. 2024;28:157-159. PubMed
PONTALI E, Akkerman OW, Zenner D, Migliori GB, et al Post-TB lung disease: keep going beyond TB!
Int J Tuberc Lung Dis. 2024;28:113-114. PubMed
THEKKUR P, Thiagesan R, Nair D, Karunakaran N, et al Using timeliness metrics for household contact tracing and TB preventive therapy
in the private sector, India.
Int J Tuberc Lung Dis. 2024;28:122-139. PubMedAbstract available
SOUSA S, Santos S, Alves CM, Goncalves G, et al Impact of annual TB screening on stone quarry workers in high-incidence
Portuguese municipalities.
Int J Tuberc Lung Dis. 2024;28:136-141. PubMedAbstract available
THOMSON H, Baines N, Huisamen T, Koegelenberg CFN, et al A new understanding of clinical patterns in post-TB lung disease.
Int J Tuberc Lung Dis. 2024;28:115-121. PubMedAbstract available
LEVER S, Akkerman OW, Dekkers BGJ Pancreatitis delays the absorption of first-line anti-TB drugs.
Int J Tuberc Lung Dis. 2024;28:163-165. PubMed
YAMKOVOY K, Self JL, Jenkins HE, Horsburgh CR, et al Patterns of TB transmission in the United States, 2011-2017.
Int J Tuberc Lung Dis. 2024;28:154-156. PubMed
REZAEE M, Azizi N, Danaei B, Davari A, et al TB and interstitial lung disease: a systematic review and meta-analysis.
Int J Tuberc Lung Dis. 2024;28:130-135. PubMedAbstract available
RUDOLF F, Abate E, Moges B, Gomes VF, et al A structured 2-week follow-up visit in the cascade of care for TB increases case
detection.
Int J Tuberc Lung Dis. 2024;28:148-153. PubMedAbstract available
LEAVITT SV, Rodriguez CA, Bouton TC, Horsburgh CR, et al Outcomes for people with TB by disease severity at presentation.
Int J Tuberc Lung Dis. 2024;28:142-147. PubMedAbstract available
February 2024
SILVA DR, Santos AP, Visca D, Bombarda S, et al The potential for vaccines to aid the treatment of post-TB lung disease.
Int J Tuberc Lung Dis. 2024;28:44-45. PubMed
LONG R, Heffernan C, Lau A Emphasis on post-TB lung disease and other sequelae of TB is good but a public
health approach to TB is morally ambitious???
Int J Tuberc Lung Dis. 2024;28:1-3. PubMed
FEKADU G, Wang Y, You JHS Cost-effectiveness of pretomanid-based regimen for highly drugresistant TB in a
low-burden setting.
Int J Tuberc Lung Dis. 2024;28:12-17. PubMedAbstract available
TURNER RD, Birring SS, Bothamley GH Measuring cough-related quality of life and cough frequency in pulmonary TB.
Int J Tuberc Lung Dis. 2024;28:25-31. PubMedAbstract available
SHIN JE, Jeon D, Mok J, Yim JJ, et al Compliance with new drug use and the effect of discrepant drug susceptibility
testing on MDR/RR-TB treatment.
Int J Tuberc Lung Dis. 2024;28:18-24. PubMedAbstract available
DOLEZALOVA K, Kika V, Wallenfels J Increasing incidence of TB in a low burden TB country due to migration from
Ukraine.
Int J Tuberc Lung Dis. 2024;28:39-40. PubMed
NIGHTINGALE ES, Feasey HRA, Khundi M, Soko RN, et al Community-level variation in TB testing history in Blantyre, Malawi.
Int J Tuberc Lung Dis. 2024;28:32-38. PubMedAbstract available
January 2024
YILDIRIM K, Bozkurt S, Basibuyuk HH, Coban AY, et al Anti-tuberculosis activity of morusin: a promising flavonoid from white mulberry.
Int J Tuberc Lung Dis. 2024;28:37-41. PubMedAbstract available
KUMAR SR, Hissar SS, Ramesh PM, Shanmugam M, et al Ethambutol-induced optic neuropathy: should we mandate ophthalmic examination in
TB treatment?
Int J Tuberc Lung Dis. 2024;28:51-53. PubMed
SURIE D, Sathyanarayanan MK, Lavanya J, Smith JP, et al Long-term follow-up of persons diagnosed with multidrug-resistant TB in Chennai,
India, 2013-2020.
Int J Tuberc Lung Dis. 2024;28:54-56. PubMed
RICCARDI N, Antonello RM, Besozzi G, Tadolini M, et al Ten common myths about drug-susceptible TB.
Int J Tuberc Lung Dis. 2024;28:61-64. PubMed
DU Y, Gu J, Yang Y, Chen Y, et al Efficacy and safety of bicyclol for treating patients with antituberculosis
drug-induced liver injury.
Int J Tuberc Lung Dis. 2024;28:6-12. PubMedAbstract available
BEELER ASAY GR, Woodruff R, Sanderson DM, Fisher CF, et al Cost-effectiveness of expanded latent TB infection testing and treatment: Lynn
City, Massachusetts, USA.
Int J Tuberc Lung Dis. 2024;28:21-28. PubMedAbstract available
SCHILDKRAUT JA, Sloan D, Boeree MJ If you want to go far, go together: standardisation and data sharing in TB drug
development.
Int J Tuberc Lung Dis. 2024;28:3-5. PubMed
HOUBEN RMGJ, McCaffrey T, Tiemersma EW, Khan PY, et al Estimating TB survival - mind the immortal-time gap.
Int J Tuberc Lung Dis. 2024;28:65-66. PubMed
YUAN S, Cui Y, Shang Y, Su F, et al Prevalence, temporal trends and risk factors of drug-resistant TB in Zibo, China,
2018-2021.
Int J Tuberc Lung Dis. 2024;28:57-58. PubMed
GEIGER K, Patil A, Bergman A, Budhathoki C, et al Exploring HIV disease indicators at MDR-TB treatment initiation in South Africa.
Int J Tuberc Lung Dis. 2024;28:42-50. PubMedAbstract available
OLIVEIRA DA SILVA B, Salindri AD, Goncalves TO, Cunha EAT, et al The impact of sputum quality on Xpert positivity in active case-finding for TB.
Int J Tuberc Lung Dis. 2024;28:29-36. PubMedAbstract available
TYUFEKCHIEVA M, Varleva T Monitoring TB infection in contact cases: the impact of the COVID-19 pandemic.
Int J Tuberc Lung Dis. 2024;28:59-60. PubMed
December 2023
YANG H, Antwi S, Maranchick N, Dompreh A, et al Effect of HIV infection on plasma exposure to first-line TB drugs and target
attainment in children.
Int J Tuberc Lung Dis. 2023;27:931-937. PubMedAbstract available
MAKEK MJ, Trauer JM, Blackbourn HD Literature Highlights.
Int J Tuberc Lung Dis. 2023;27:882-884. PubMedAbstract available
ARAUJO-PEREIRA M, Andrade BB Atorvastatin to reduce bacillary load and attenuate lung damage in TB patients.
Int J Tuberc Lung Dis. 2023;27:880-881. PubMed
COMMIESIE E, Stijnberg D, van den Boogaard J, Gopie F, et al Challenges and opportunities for TB elimination in Suriname.
Int J Tuberc Lung Dis. 2023;27:946-948. PubMed
RAGHEB SM, White JB, Jarand J, Fisher DA, et al Assessing patient satisfaction with video-supported therapy for drug-susceptible
TB treatment.
Int J Tuberc Lung Dis. 2023;27:938-940. PubMed
CHUNG C, Jo KW, Shim TS Treatment outcome, recurrence and safety of multidrug-resistant TB treated with
low-dose linezolid.
Int J Tuberc Lung Dis. 2023;27:918-924. PubMedAbstract available
DU CROS P, Greig J, Alffenaar JC, Cross GB, et al Standards for clinical trials for treating TB.
Int J Tuberc Lung Dis. 2023;27:885-898. PubMedAbstract available
ADEWOLE OO, Omotoso BA, Ogunsina M, Aminu A, et al Atorvastatin improves sputum conversion and chest X-ray severity score.
Int J Tuberc Lung Dis. 2023;27:912-917. PubMedAbstract available
QUINCER EM, Lyland A, Onyango D, LaCourse SM, et al The effect of antenatal isoniazid preventive therapy on birth outcomes in Western
Kenya.
Int J Tuberc Lung Dis. 2023;27:906-911. PubMedAbstract available
NETO ERD, Matos TS, Ferreira ACF, Bezerra-Santos M, et al The impact of COVID-19 on TB care in Brazil.
Int J Tuberc Lung Dis. 2023;27:941-943. PubMed
MENDOZA-TICONA A, Mitnick CD, Obregon G, Alarcon V, et al Screening with GenoType((R)) MTBDRplus shortens the time to MDR-TB treatment
initiation but does not change outcomes.
Int J Tuberc Lung Dis. 2023;27:949-951. PubMed
KIBIRIGE D, Andia-Biraro I, Olum R, Adakun S, et al Metabolic characterisation of adult Ugandan patients with TB and diabetes
mellitus comorbidity.
Int J Tuberc Lung Dis. 2023;27:944-945. PubMed
November 2023
EDWARDS S, Humbert T, Berdzuli N, Azzopardi-Muscat N, et al Tackling TB in Europe: treatment gaps and deteriorating treatment availability is
undermining progress.
Int J Tuberc Lung Dis. 2023;27:793-796. PubMed
MARGINEANU I, Butnaru T, Gafar F, Baiceanu D, et al TB therapeutic drug monitoring - analysis of opportunities in Romania and
Ukraine.
Int J Tuberc Lung Dis. 2023;27:816-821. PubMedAbstract available
KATRAK S, Wang R, Barry P Costs of treating multidrug-resistant TB in California in 2022.
Int J Tuberc Lung Dis. 2023;27:864-866. PubMed
TANEJA R, Nahata MC, Scarim J, Pande PG, et al A novel home-based method for preparing suspensions of anti-TB drugs.
Int J Tuberc Lung Dis. 2023;27:810-815. PubMedAbstract available
INBARAJ LR, Rade K, Selvaraju S, Rao R, et al Mortality estimates of central nervous system TB in India.
Int J Tuberc Lung Dis. 2023;27:876-877. PubMed
FRITSCHI N, Vaezipour N, Buettcher M, Portevin D, et al Ratios from full blood count as markers for TB diagnosis, treatment, prognosis: a
systematic review.
Int J Tuberc Lung Dis. 2023;27:822-832. PubMedAbstract available
October 2023
ANDREWS F, Welch S, Scandrett K, Kaur H, et al Outcomes of TB contact tracing and predictors of success: a 10-year retrospective
cohort analysis in Birmingham, UK.
Int J Tuberc Lung Dis. 2023;27:766-771. PubMedAbstract available
TRAUER JM, Tiberi S, Graham SM, Blackbourn HD, et al Literature Highlights.
Int J Tuberc Lung Dis. 2023;27:721-723. PubMedAbstract available
NELSON KN, Shah NS, Cranmer LM, Vasudevan L, et al An effective vaccine is only the first step: the need to create and sustain
demand for TB vaccines.
Int J Tuberc Lung Dis. 2023;27:718-720. PubMed
PUMA D, Geadas C, Calderon RI, Yuen CM, et al Active case-finding for TB among incarcerated women in Peru.
Int J Tuberc Lung Dis. 2023;27:784-786. PubMed
AKKERMAN OW, Dijkwel RDC, Kerstjens HAM, van der Werf TS, et al Isoniazid and rifampicin exposure during treatment in drug-susceptible TB.
Int J Tuberc Lung Dis. 2023;27:772-777. PubMedAbstract available
CHIANG SS, Zeng C, Roman-Sinche B, Altamirano E, et al Adaptation and validation of a TB stigma scale for adolescents in Lima, Peru.
Int J Tuberc Lung Dis. 2023;27:754-760. PubMedAbstract available
KIM JY, Koo B, Lim SY, Cha HH, et al A non-invasive, sensitive assay for active TB: combined cell-free DNA detection
and FluoroSpot assays.
Int J Tuberc Lung Dis. 2023;27:790-792. PubMed
REKART ML, Aung A, Cullip T, Mulanda W, et al Household drug-resistant TB contact tracing in Tajikistan.
Int J Tuberc Lung Dis. 2023;27:748-753. PubMedAbstract available
RAJAVARDHANA T, Koushik MR, Jayakumar C, Ramalingam P, et al Adherence to treatment on a daily-dose regimen for TB.
Int J Tuberc Lung Dis. 2023;27:778-780. PubMed
SINGH UB, Ray Y, Kanswal S, Sharma HP, et al Low rifampicin levels in plasma associated with a poor clinical response in
patients with abdominal TB.
Int J Tuberc Lung Dis. 2023;27:787-789. PubMed
FRAZIER C, Nabity SA, Flood J Incidence of TB disease among persons who use drugs in California.
Int J Tuberc Lung Dis. 2023;27:781-783. PubMed
RAJENDRAN P, Saini S, Kumar N, Vashistha H, et al Establishing proof of concept for utility of Trueprep((R))-extracted DNA in
line-probe assay testing.
Int J Tuberc Lung Dis. 2023;27:742-747. PubMedAbstract available
September 2023
MACHAVARIANI E, Nonyane BAS, Lebina L, Mmolawa L, et al Perceived stigma among people with TB and household contacts.
Int J Tuberc Lung Dis. 2023;27:675-681. PubMedAbstract available
VILJOEN L, Acaba J, Agbassi YJP, Beko B, et al Community perspective on child-friendly medications for drug-resistant TB:
importance, priorities and advocacy.
Int J Tuberc Lung Dis. 2023;27:655-657. PubMed
RODRIGUEZ CA, Leavitt SV, Bouton TC, Horsburgh CR, et al Survival of people with untreated TB: effects of time, geography and setting.
Int J Tuberc Lung Dis. 2023;27:694-702. PubMedAbstract available
BECKER GL, Amuge P, Ssebunya R, Motevalli M, et al Predictors of mortality in Ugandan children with TB, 2016-2021.
Int J Tuberc Lung Dis. 2023;27:668-674. PubMedAbstract available
DO NASCIMENTO DR, Serpa SF, Bezerra-Santos M, do Carmo RF, et al The impact of the COVID-19 pandemic on TB diagnosis in the Brazilian prison
population, 2020-2021.
Int J Tuberc Lung Dis. 2023;27:688-693. PubMedAbstract available
GALEA JT, Chu AL, Sweetland AC, Jimenez J, et al Latent TB and depressive symptoms in household contacts of persons with active
TB.
Int J Tuberc Lung Dis. 2023;27:682-687. PubMedAbstract available
August 2023
SILVA DR, Munoz-Torrico M, Fernandes GR, Narvaez-Diaz L, et al Isoniazid-resistant TB: treatment outcomes and impact of regimens with
fluoroquinolones.
Int J Tuberc Lung Dis. 2023;27:638-640. PubMed
AHMED S, Lotia-Farrukh I, Khan PY, Adnan S, et al High prevalence of multidrug-resistant TB among household contacts in a high
burden setting.
Int J Tuberc Lung Dis. 2023;27:646-648. PubMed
CHIANG SS, Graham SM, Schaaf HS, Marais BJ, et al Clinical standards for drug-susceptible TB in children and adolescents.
Int J Tuberc Lung Dis. 2023;27:584-598. PubMedAbstract available
MAKEK MJ, Amorim GGC, Ragonnet R, Blackbourn HD, et al Literature Highlights.
Int J Tuberc Lung Dis. 2023;27:581-583. PubMedAbstract available
ACUNA-VILLAORDUNA C, Jacobson KR, Horsburgh CR, Canning M, et al Initial experience with BPaL-based regimens to treat multidrug-resistant TB.
Int J Tuberc Lung Dis. 2023;27:649-650. PubMed
HACKER B, Breuer C, Priwitzer M, Otto-Knapp R, et al TB screening of Ukrainian refugees in Germany.
Int J Tuberc Lung Dis. 2023;27:641-642. PubMed
HONGPRASIT P, Sonthisombat P Assessment of TB treatment adherence using computer-assisted self-interviewing.
Int J Tuberc Lung Dis. 2023;27:626-631. PubMedAbstract available
RIKHOTSO MC, Ledwaba SE, Ngandu JK, Mavumengwana V, et al Favourable outcomes in RR-TB patients using BPaL and other WHO-recommended
second-line anti-TB drugs.
Int J Tuberc Lung Dis. 2023;27:599-605. PubMedAbstract available
MARITZ ER, Montepiedra G, Mitchell CD, Madhi SA, et al Predictors of TB disease in HIV-exposed children from Southern Africa.
Int J Tuberc Lung Dis. 2023;27:619-625. PubMedAbstract available
CHIBOLELA M, de Haas P, Klinkenberg E, Kosloff B, et al Use of stool swabs in molecular transport media increases access to Xpert Ultra
testing for TB in children.
Int J Tuberc Lung Dis. 2023;27:612-618. PubMedAbstract available
HABIB SS, Uzair M, Dhanwani A, Sohail K, et al A model for integrating social protection measures with TB control in Pakistan.
Int J Tuberc Lung Dis. 2023;27:651-652. PubMed
RACHOW A, Ivanova O, Bakuli A, Khosa C, et al Performance of spirometry assessment at TB diagnosis.
Int J Tuberc Lung Dis. 2023;27:850-857. PubMedAbstract available
SALERNO MM, Burzynski J, Mangan JM, Hill A, et al Adverse events among persons with TB using in-person vs. electronic directly
observed therapy.
Int J Tuberc Lung Dis. 2023;27:833-840. PubMedAbstract available
OWOLABI OA, Sillah AK, Loum I, Touray A, et al Factors associated with presenting to private sector care providers at the onset
of TB symptoms.
Int J Tuberc Lung Dis. 2023;27:867-868. PubMed
SILVESTRE CR, Cavaco M, Afonso R, Alves S, et al TB infection in healthcare workers - the reality of a Portuguese hospital.
Int J Tuberc Lung Dis. 2023;27:874-875. PubMed
CHO MM, Kim HW, Kim JS, Min J, et al TB in ageing populations: lessons from Japan and Korea.
Int J Tuberc Lung Dis. 2023;27:869-871. PubMed
July 2023
NUR N, Sharif AB, Mitra DK Stress resilience in patients with drug-resistant TB.
Int J Tuberc Lung Dis. 2023;27:551-556. PubMedAbstract available
OKOYA F, Huang CC, Zhang Z, Lecca L, et al Culture-negative TB: clinical characteristics, risk factors and treatment
outcomes.
Int J Tuberc Lung Dis. 2023;27:557-563. PubMedAbstract available
ESCALANTE P, Vadiyala MR, Pathakumari B, Marty PK, et al New diagnostics for the spectrum of asymptomatic TB: from infection to
subclinical disease.
Int J Tuberc Lung Dis. 2023;27:499-505. PubMedAbstract available
STRAUSS M, Wademan DT, Mcinziba A, Hoddinott G, et al TB preventive therapy preferences among children and adolescents.
Int J Tuberc Lung Dis. 2023;27:520-529. PubMedAbstract available
HARRIES AD, Lin Y, Thekkur P, Nair D, et al Why TB programmes should assess for comorbidities, determinants and disability at
the start and end of TB treatment.
Int J Tuberc Lung Dis. 2023;27:495-498. PubMed
GLOGOWSKA A, Przybylski G, Bukowski J, Dolska E, et al TB and COVID-19 co-infection in a pulmonology hospital.
Int J Tuberc Lung Dis. 2023;27:574-576. PubMed
FERRARESE M, Antonello RM, Torri S, Saderi L, et al Extrapulmonary TB: a 30-year observational study of an Italian cohort.
Int J Tuberc Lung Dis. 2023;27:564-566. PubMed
WADEMAN DT, Viljoen L, Jacobs S, Meyerson K, et al Children s priorities to improve the acceptability of MDR-TB treatment:
qualitative data from South Africa.
Int J Tuberc Lung Dis. 2023;27:543-550. PubMedAbstract available
SINGH KP, Carvalho ACC, Centis R, D Ambrosio L, et al Clinical standards for the management of adverse effects during treatment for TB.
Int J Tuberc Lung Dis. 2023;27:506-519. PubMedAbstract available
MARQUES J, Rocha JV, Soares P, Leite A, et al The effect of TB patient delay on loss to follow-up in Portugal.
Int J Tuberc Lung Dis. 2023;27:537-542. PubMedAbstract available
CENTENO HURTADO KT, Garcia Bohorquez DF, Ruiz Gonzalez CE, Masias Leon Y, et al The burden of chronic obstructive pulmonary disease among hospitalised women in a
developing country.
Int J Tuberc Lung Dis. 2023;27:530-536. PubMedAbstract available
VENGURLEKAR D, Walker C, Mahajan R, Dalal A, et al Linezolid resistance in patients with drug-resistant TB.
Int J Tuberc Lung Dis. 2023;27:567-569. PubMed
ZUREIGAT H, Alhusban M, Nawaiseh M, Alomari L, et al Steps towards TB elimination in Jordan.
Int J Tuberc Lung Dis. 2023;27:576-577. PubMed
June 2023
DE VRIES G, Akkerman O, Boeree M, van Hest R, et al Diagnosis, treatment and transmission of rifampicin-resistant TB in the
Netherlands, 2010-2019.
Int J Tuberc Lung Dis. 2023;27:471-477. PubMedAbstract available
MALHOTRA A, Mukiibi J, Kitonsa PJ, Nalutaaya A, et al Higher yield using an event-based vs. door-to-door approach for active
case-finding for TB.
Int J Tuberc Lung Dis. 2023;27:484-486. PubMed
MAKEK MJ, Tiberi S, Felker I, Amorim GGC, et al Literature Highlights.
Int J Tuberc Lung Dis. 2023;27:429-431. PubMedAbstract available
NI N, Wang N, Veronese V, Wang MZ, et al Current status and future prospects of TB digital treatment adherence technology
use in China.
Int J Tuberc Lung Dis. 2023;27:438-443. PubMedAbstract available
KIM SH, Yoo JY, Cho HS, Kim SR, et al Clinical and imaging features of drug-susceptible and multidrug-resistant TB in
Korean adults.
Int J Tuberc Lung Dis. 2023;27:487-489. PubMed
LOUIE JK, Keh C, Agraz-Lara R, Phillips A, et al Highlighting the characteristics of TB disease in older people.
Int J Tuberc Lung Dis. 2023;27:478-480. PubMed
SUNG J, Musinguzi A, Kadota JL, Baik Y, et al Understanding patient-level costs of weekly isoniazid-rifapentine (3HP) among
people living with HIV in Uganda.
Int J Tuberc Lung Dis. 2023;27:458-464. PubMedAbstract available
OESER C, Rangaka MX, Abubakar I Digital approaches to reducing TB treatment loss to follow-up.
Int J Tuberc Lung Dis. 2023;27:432-437. PubMedAbstract available
RICH ML, Khan U, Zeng C, LaHood A, et al Outcomes of WHO-conforming, longer, all-oral multidrug-resistant TB regimens and
analysis implications.
Int J Tuberc Lung Dis. 2023;27:451-457. PubMedAbstract available
MYERS B, Carney T, Rooney J, Malatesta S, et al Smoked drug use in patients with TB is associated with higher bacterial burden.
Int J Tuberc Lung Dis. 2023;27:444-450. PubMedAbstract available
OTAALO B, Cevik M, Mwebesa E, Nabisere-Arinaitwe R, et al Prevalence of COVID-19 infection in TB clinics in Kampala, Uganda.
Int J Tuberc Lung Dis. 2023;27:481-483. PubMed
May 2023
GUNTHER G, Guglielmetti L, Leu C, van Leth F, et al Relative cost of multidrug-resistant TB medicines in Europe.
Int J Tuberc Lung Dis. 2023;27:341-344. PubMed
KWARA A, Yang H, Martyn-Dickens C, Enimil A, et al Adequacy of WHO weight-band dosing and fixed-dose combinations for the treatment
of TB in children.
Int J Tuberc Lung Dis. 2023;27:401-407. PubMedAbstract available
GIRIDHARAN P, Devaleenal B, Thiruvengadam K, Kaleeswari M, et al A novel method for contact tracing for TB at household and community level.
Int J Tuberc Lung Dis. 2023;27:414-415. PubMed
SADERI L, Cabibbe AM, Puci M, Di Lorenzo B, et al A systematic review of the costs of diagnosis for multidrug-resistant/extensively
drug-resistant TB in different settings.
Int J Tuberc Lung Dis. 2023;27:348-356. PubMedAbstract available
GERIC C, Qin ZZ, Denkinger CM, Kik SV, et al The rise of artificial intelligence reading of chest X-rays for enhanced TB
diagnosis and elimination.
Int J Tuberc Lung Dis. 2023;27:367-372. PubMedAbstract available
FAJER EB, Costa FD, Pelissari DM, Diaz Quijano FA, et al Use of rapid molecular TB diagnostics for incarcerated people in Brazil.
Int J Tuberc Lung Dis. 2023;27:416-418. PubMed
KASWASWA K, Mlauzi L, Mpunga J, Mandambwe C, et al Use of local data to evaluate TB contact investigation in Malawi.
Int J Tuberc Lung Dis. 2023;27:408-410. PubMed
TANG J, Tang Z, Feng C, Tang Q, et al Efficacy and safety of video-assisted thoracoscopic surgery for pulmonary TB.
Int J Tuberc Lung Dis. 2023;27:387-394. PubMedAbstract available
MAUGANS C, Loveday M, Hlangu S, Waitt C, et al Best practices for the care of pregnant people living with TB.
Int J Tuberc Lung Dis. 2023;27:357-366. PubMedAbstract available
TAGUIBAO C, Lailo JM, Neukom J, Gones V, et al Digital survey results on pharmacy access to fixed-dose combination drugs for TB
in Indonesia.
Int J Tuberc Lung Dis. 2023;27:422-424. PubMed
MOE S, Rekart ML, Hernandez D, Sholpan A, et al Primary bedaquiline resistance in Karakalpakstan, Uzbekistan.
Int J Tuberc Lung Dis. 2023;27:381-386. PubMedAbstract available
AHMED R, Osman N, Noory B, Osman R, et al Prevalence and determinants of chronic respiratory diseases in adults in Sudan.
Int J Tuberc Lung Dis. 2023;27:373-380. PubMedAbstract available
PAREDES JL, Picon V, Reynolds L, Ugarte-Gil C, et al Impact of the COVID-19 pandemic on TB care in Peru.
Int J Tuberc Lung Dis. 2023;27:411-413. PubMed
MUTEMBA CM, Schindele A, Munyangaju I, Ramanlal N, et al Contribution of Xpert((R)) MTB/RIF to pediatric TB diagnosis in Mozambique.
Int J Tuberc Lung Dis. 2023;27:419-421. PubMed
April 2023
GRIJOTA-CAMINO MD, Perez-Recio S, Trapero C, Luque MJ, et al Identifying gaps in the cascade of care for latent TB infection in a
low-incidence setting.
Int J Tuberc Lung Dis. 2023;27:315-321. PubMedAbstract available
VELEN K, Nguyen TA, Pham CD, Le HT, et al The effect of medication event reminder monitoring on treatment adherence of TB
patients.
Int J Tuberc Lung Dis. 2023;27:322-328. PubMedAbstract available
BOLHUIS MS, Akkerman OW, Sturkenboom MGG, van Boven JFM, et al Bedaquiline exposure in people with drug-resistant TB treated for diabetes:
analysis of two phase 2 trials.
Int J Tuberc Lung Dis. 2023;27:335-337. PubMed
GOLETTI D, Pisapia R, Fusco FM, Aiello A, et al Epidemiology, pathogenesis, clinical presentation and management of TB in
patients with HIV and diabetes.
Int J Tuberc Lung Dis. 2023;27:284-290. PubMedAbstract available
MIGLIORI GB, Blackbourn HD Post-TB lung disease - the rationale for a Clinical Statement.
Int J Tuberc Lung Dis. 2023;27:243-244. PubMed
CAMPBELL JR, Chan ED, Anderson LF, Bonnet M, et al Association of smoking and alcohol use with rifampin-resistant TB treatment
outcomes.
Int J Tuberc Lung Dis. 2023;27:338-340. PubMed
SACHDEVA KS, Bhatnagar AK, Bhaskar A, Singla N, et al QTc prolongation with bedaquiline treatment for drug-resistant pulmonary TB in a
programmatic setting.
Int J Tuberc Lung Dis. 2023;27:329-331. PubMed
KAZIBWE A, Kyazze AP, Ssekamatte P, Mutebi EI, et al TB infection in adults with diabetes mellitus in Uganda.
Int J Tuberc Lung Dis. 2023;27:308-314. PubMedAbstract available
NIGHTINGALE R, Carlin F, Meghji J, McMullen K, et al Post-TB health and wellbeing.
Int J Tuberc Lung Dis. 2023;27:248-283. PubMedAbstract available
MANGAN JM, Burzynski J, deCastro BR, Salerno MM, et al Challenges associated with electronic and in-person directly observed therapy
during a randomized trial.
Int J Tuberc Lung Dis. 2023;27:298-307. PubMedAbstract available
KINTU TM, Mwanahamisi BS, Muwanguzi M, Kyagambiddwa T, et al Unfavorable treatment outcomes among patients with drug-resistant TB in Uganda.
Int J Tuberc Lung Dis. 2023;27:291-297. PubMedAbstract available
March 2023
COLA JP, Nascimento do Prado T, Alves KBA, Lapa E Silva JR, et al Factors associated with non-completion of TB preventive treatment in Brazil.
Int J Tuberc Lung Dis. 2023;27:215-220. PubMedAbstract available
HUDDART S, Asege L, Jaganath D, Golla M, et al Continuous cough monitoring: a novel digital biomarker for TB diagnosis and
treatment response monitoring.
Int J Tuberc Lung Dis. 2023;27:221-222. PubMed
YAACOUB H, Farhat AM, Najjar-Pellet J, Zgheib J, et al Planning for TB elimination in Lebanon.
Int J Tuberc Lung Dis. 2023;27:171-174. PubMed
KWON YS, Jang JG, Lee J, Choi KJ, et al Risk factors for peripheral neuropathy in patients on linezolid-containing
regimens for drug-resistant TB.
Int J Tuberc Lung Dis. 2023;27:232-234. PubMed
PALACIOS CF, Hough MA, Shrestha R, Moll AP, et al Perceived stigma related to TB preventive therapy.
Int J Tuberc Lung Dis. 2023;27:209-214. PubMedAbstract available
AKKERMAN OW, van Het Hof S, de Vries G, van Crevel R, et al Characteristics and mortality of central nervous system TB in the Netherlands: a
15-year comparison with other forms of TB.
Int J Tuberc Lung Dis. 2023;27:237-239. PubMed
HUAROTO L, Huaman MA, Mugruza R, Ticona C, et al Active case-finding of pulmonary TB in an urban emergency department.
Int J Tuberc Lung Dis. 2023;27:202-208. PubMedAbstract available
ADEWOLE OO, Omotoso BA, Ogunsina M, Aminu A, et al Atorvastatin accelerates Mycobacterium tuberculosis clearance in pulmonary TB: a
randomised phase IIA trial.
Int J Tuberc Lung Dis. 2023;27:226-228. PubMed
MALIK AA, Jaswal M, Siddiqui S, Amanullah F, et al Role of symptom and chest X-ray screening in evaluating child household contacts
for pulmonary TB.
Int J Tuberc Lung Dis. 2023;27:235-236. PubMed
TRAUER JM Targeted TB control in migrants to low-burden countries.
Int J Tuberc Lung Dis. 2023;27:169-170. PubMed
MARTINEZ-GARCIA MA, Guan WJ, de-la-Rosa D, Athanazio R, et al Post-TB bronchiectasis: from pathogenesis to rehabilitation.
Int J Tuberc Lung Dis. 2023;27:175-181. PubMedAbstract available
TANEJA R, Nahata MC, Scarim J, Pande PG, et al Stable, compounded bedaquiline suspensions to support practical implementation of
pediatric dosing in the field.
Int J Tuberc Lung Dis. 2023;27:189-194. PubMedAbstract available
DAMARAJU V, Singh N, Garg M, Kathirvel S, et al Effect of prior pulmonary TB on low-dose computed tomography during lung cancer
screening.
Int J Tuberc Lung Dis. 2023;27:223-225. PubMed
SPRUIJT I, Erkens C, Greenaway C, Mulder C, et al Reducing the burden of TB among migrants to low TB incidence countries.
Int J Tuberc Lung Dis. 2023;27:182-188. PubMedAbstract available
BAIK Y, Nakasolya O, Isooba D, Mukiibi J, et al Cost to perform door-to-door universal sputum screening for TB in a high-burden
community.
Int J Tuberc Lung Dis. 2023;27:195-201. PubMedAbstract available
February 2023
CHUNG C, Shin JE, Jeon D, Kang H, et al Treatment outcomes and safety of bedaquiline, delamanid, and linezolid in
multidrug-resistant TB.
Int J Tuberc Lung Dis. 2023;27:151-153. PubMed
GOMES I, Garg T, Churchyard G, Gupta A, et al The cascade of care for household contacts of people with drug-resistant TB.
Int J Tuberc Lung Dis. 2023;27:154-156. PubMed
TOCHAENG C, Eksombatchai D, Boonsarngsuk V Factors associated with false-negative for T-SPOT.TB in patients with TB disease.
Int J Tuberc Lung Dis. 2023;27:128-134. PubMedAbstract available
ALKABAB Y, Warkentin J, Cummins J, Katz B, et al Therapeutic drug monitoring and TB treatment outcomes in patients with diabetes
mellitus.
Int J Tuberc Lung Dis. 2023;27:135-139. PubMedAbstract available
FORSMAN LD, Alffenaar JWC Diabetes mellitus and TB - finding strategies to reduce the double burden of
disease.
Int J Tuberc Lung Dis. 2023;27:91-93. PubMed
BARKER M, Gunther A, Wurps H, Gebhardt A, et al Ultrasound-guided lymph node biopsy in smear-negative children and adolescents
with suspected TB.
Int J Tuberc Lung Dis. 2023;27:164-165. PubMed
BOLSTERLI E, Keller PM, Suter-Riniker F, Kruger L, et al A comparison of bronchoalveolar lavage and gastric aspirate for diagnosis of
paediatric TB.
Int J Tuberc Lung Dis. 2023;27:148-150. PubMed
VILLA S, Carugati M, Rubach MP, Cleaveland S, et al 'One Health approach to end zoonotic TB.
Int J Tuberc Lung Dis. 2023;27:101-105. PubMedAbstract available
BALTAS I, Sturdy A, Kavallieros K, McGregor A, et al Diabetes mellitus is not a predictor of poor TB treatment outcomes.
Int J Tuberc Lung Dis. 2023;27:140-145. PubMedAbstract available
CHUKWUOGO O, Odume B, Ogbudebe C, Useni S, et al Strategic approach to optimisation of TB contact investigation in Nigeria.
Int J Tuberc Lung Dis. 2023;27:161-163. PubMed
PAUDEL K, Nalutaaya A, Robsky KO, Kitonsa PJ, et al The impact of time at home on potential yield of home-based TB contact
investigation.
Int J Tuberc Lung Dis. 2023;27:121-127. PubMedAbstract available
KOESOEMADINATA RC, McAllister SM, Soetedjo NNM, Santoso P, et al Diabetes characteristics and long-term management needs in diabetic TB patients.
Int J Tuberc Lung Dis. 2023;27:113-120. PubMedAbstract available
TANEJA R, Nahata MC, Scarim J, Pande PG, et al Extemporaneously compounded liquid formulations of clofazimine.
Int J Tuberc Lung Dis. 2023;27:106-112. PubMedAbstract available
GENADE LP, Kahamba T, Scott L, Tempia S, et al Co-testing a single sputum specimen for TB and SARS-CoV-2.
Int J Tuberc Lung Dis. 2023;27:146-147. PubMed
January 2023
KHAN U, Guglielmetti L Tailored TPT for drug-resistant TB - promoting equity and access to optimal care.
Int J Tuberc Lung Dis. 2023;27:89b-90. PubMed
MANSOOR H, Hirani N, Chavan V, Das M, et al Clinical utility of target-based next-generation sequencing for drug-resistant
TB.
Int J Tuberc Lung Dis. 2023;27:41-48. PubMedAbstract available
GILLESPIE SH Improving outcomes for multidrug-resistant TB: the role of integrated systems.
Int J Tuberc Lung Dis. 2023;27:1-2. PubMed
SEHGAL IS, Muthu V, Agarwal R Aspergillus infection is an important complication of post-TB bronchiectasis.
Int J Tuberc Lung Dis. 2023;27:89a-89. PubMed
OLARU ID, Beliz Meier M, Schumacher SG, Prodanovic N, et al Co-administration of treatment for drug-resistant TB and hepatitis C.
Int J Tuberc Lung Dis. 2023;27:66-68. PubMed
FELKER I, Trajman A Shorter regimens for multidrug-/rifampicin-resistant TB.
Int J Tuberc Lung Dis. 2023;27:3-4. PubMed
KWON YS, Shin JE, Kang H, Jeon D, et al Treatment outcomes of multidrug-resistant TB with selective use of new drugs.
Int J Tuberc Lung Dis. 2023;27:55-60. PubMedAbstract available
ZENG C, Mitnick CD, Hewison C, Bastard M, et al Concordance of three approaches for operationalizing outcome definitions for
multidrug-resistant TB.
Int J Tuberc Lung Dis. 2023;27:34-40. PubMedAbstract available
CANTERA JL, Rashid AA, Lillis LM, Peck RB, et al Isolation and purification of lipoarabinomannan from urine of adults with active
TB.
Int J Tuberc Lung Dis. 2023;27:75-77. PubMed
KNUDSEN S, Babu SP, Ramakrishnan J, Jenkins HE, et al M. tuberculosis infection before, during and after pregnancy.
Int J Tuberc Lung Dis. 2023;27:72-74. PubMed
ATSHEMYAN H, Khachatryan N, Manukyan A, Khachatryan A, et al Implementation of modified, all-oral shorter TB regimens in Armenia.
Int J Tuberc Lung Dis. 2023;27:84-85. PubMed
BUTOV D, Feshchenko Y, Chesov D, Myasoedov V, et al National survey on the impact of the war in Ukraine on TB diagnostics and
treatment services in 2022.
Int J Tuberc Lung Dis. 2023;27:86-88. PubMed
TANEJA R, Nahata MC, Scarim J, Pande PG, et al Sugar and sugar-free liquid formulations of delamanid for patients with
rifampicin-resistant TB.
Int J Tuberc Lung Dis. 2023;27:13-18. PubMedAbstract available
MAH JK, Lieu A, Fisher D, Lim RK, et al Impact of the COVID-19 pandemic on the epidemiology of TB in a low-incidence
setting.
Int J Tuberc Lung Dis. 2023;27:69-71. PubMed
COX SR, Padmapriyadarsini C, Mave V, Seth B, et al Characterising cause of death among people treated for drug-susceptible TB in
India.
Int J Tuberc Lung Dis. 2023;27:78-80. PubMed
JAW-TSAI S, Barry R, Pande PG, Taneja R, et al Comparison of pharmacokinetics and bioavailability of bedaquiline fumarate,
benzoate and maleate in dogs.
Int J Tuberc Lung Dis. 2023;27:28-33. PubMedAbstract available
DE HAAS P, Nhung NV, Hng NT, Hoa NB, et al Introduction of the Simple One-Step stool Xpert Ultra method to detect TB in
children and adults.
Int J Tuberc Lung Dis. 2023;27:19-27. PubMedAbstract available